Kevin Patrick Moran
Known title: SVP, CFO & TreasurerCIK: 0001806596
Kevin Patrick Moran's purchase track record
Kevin Patrick Moran has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/21/2025 | VNDA | $9K | -2.3% | +7.2% | +7.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| VNDA | ▼ Sell | Open Market | 42,442 | $351K | 3/2/2026 | View on chart |
| VNDA | ▲ Buy | Grant | 125,000 | $0 | 2/18/2026 | View on chart |
| VNDA | ▼ Sell | Tax Withholding | 26,941 | $128K | 3/1/2025 | View on chart |
| VNDA | ▲ Buy | Open Market | 2,000 | $9K | 2/21/2025 | View on chart |
| VNDA | ▲ Buy | Grant | 125,000 | $0 | 2/18/2025 | View on chart |
| VNDA | ▼ Sell | Open Market | 2,251 | $13K | 7/29/2024 | View on chart |
| VNDA | ▼ Sell | Open Market | 8,902 | $37K | 3/5/2024 | View on chart |
| VNDA | ▼ Sell | Open Market | 5,798 | $26K | 3/4/2024 | View on chart |
| VNDA | ▲ Buy | Grant | 125,000 | $0 | 2/16/2024 | View on chart |
| VNDA | ▼ Sell | Open Market | 1,800 | $11K | 7/28/2023 | View on chart |
| VNDA | ▼ Sell | Open Market | 412 | $3K | 7/28/2023 | View on chart |
| VNDA | ▼ Sell | Open Market | 16,000 | $101K | 6/15/2023 | View on chart |
| VNDA | ▼ Sell | Open Market | 5,968 | $37K | 3/3/2023 | View on chart |
| VNDA | ▼ Sell | Open Market | 7,966 | $50K | 3/2/2023 | View on chart |
| VNDA | ▲ Buy | Grant | 32,700 | $0 | 2/16/2023 | View on chart |
| VNDA | ▲ Buy | Option Exercise | 7,500 | $23K | 12/6/2022 | View on chart |
| VNDA | ▼ Sell | Open Market | 4,792 | $51K | 12/6/2022 | View on chart |
| VNDA | ▼ Sell | Open Market | 2,239 | $25K | 7/28/2022 | View on chart |
| VNDA | ▼ Sell | Open Market | 8,832 | $100K | 3/2/2022 | View on chart |
| VNDA | ▼ Sell | Open Market | 3,473 | $39K | 3/1/2022 | View on chart |
| VNDA | ▲ Buy | Grant | 32,700 | $0 | 2/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Oppenheimer Launches Coverage on Vanda Pharmaceuticals
Oppenheimer has begun covering Vanda Pharmaceuticals, issuing an outperform rating and a $10 price target. The target sits near the middle of the analyst range and below the 52‑week high, suggesting a cautious upside view. The stock is trading above its $5.21 support level with an RSI of 41.6, indicating room for movement.
Oppenheimer Launches Coverage on Vanda Pharmaceuticals. Oppenheimer has begun covering Vanda Pharmaceuticals, issuing an outperform rating and a $10 price target. The target sits near the middle of the analyst range and below the 52‑week high, suggesting a cautious upside view. The stock is trading above its $5.21 support level with an RSI of 41.6, indicating room for movement.